Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
16.85 -0.69 / -3.93%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.85 0.00 / 0.00%
 
Volume: 34.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash----21.6M61.4M
 
 
 
Short Term Investment Cash-30.4M47.1M-72.0M34.0M
 
 
 
 
 
Cash & Short Term Investments52.8M99.9M71.5M135.6M
 
 
 
 
 
 
ReceivablesReceivables2.3M15.7M9.1M9.1M
 
 
 
 
 
 
InventoriesInventories567.3K2.7M6.2M6.4M
 
 
 
 
 
 
Current AssetsOther Current Assets8.3M12.8M8.4M10.1M
 
 
 
 
 
Current Assets64.0M131.0M95.2M161.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross7.5M10.4M11.1M12.2M
 
 
 
 
 
Depreciation-5.7M-6.7M-7.6M-9.2M
 
 
 
 
 
Other Assets0.000.002.7M1.2M
 
 
 
Total Assets65.8M134.7M101.8M166.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable7.6M2.3M3.1M3.0M
 
 
 
 
 
Accrued Expenses2.4M3.7M7.8M8.0M
 
 
 
 
 
Other Current Liabilities6.5M12.6M15.2M15.4M
 
 
 
 
 
Other Liabilities17.3M18.9M25.5M24.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0031.1M49.8M49.9M
 
 
 
 
Other Liabilities0.000.0018.3K3.2M
 
 
 
Total Liabilities54.9M85.9M121.8M124.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity10.9M48.9M-20.0M41.4M
 
 
 
 
 
Total Shareholder Equity10.9M48.9M-20.0M41.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding104.0M112.7M114.5M125.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.